BioSpace News Archive

Drug Development

Pfizer Release: First Positive Phase 3 Results In Adjuvant Setting For Renal Cell Carcinoma Show SUTENT (sunitinib) Extended Disease Free Survival After Surgical Removal

October 10, 2016
·
16 min read
Pharm Country

SIGA Announces Oct. 12 Record Date For Rights Offering

October 10, 2016
·
4 min read
Business

Envirotainer AB: New Head Of Operations APAC At Envirotainer

October 10, 2016
·
1 min read
Unibio Completes Final Upgrades To Its Market-Leading Technology And Process Ahead Of Commencement Of Large Scale Commercial Phase

October 10, 2016
·
2 min read
Lone Star Bio

Rice University Release: Eco-Detector Will Hunt GMOs That Escape To Environment

October 10, 2016
·
4 min read
Drug Development

Xenetic Biosciences Reports Positive Topline Data From Third Cohort Of Phase 2 Dose-Escalation Trial Of Erepoxen For Anemia

October 10, 2016
·
7 min read
Drug Development

Ariad Presents Updated Long-Term Follow-Up Results From The Phase 1/2 Trial On Investigational Drug Brigatinib At 2016 ESMO Meeting

October 10, 2016
·
8 min read
Janssen-Cilag International NV Release:Treatment Outcome Data From The Prostate Cancer Registry Presented For The First Time At The 2016 European Society For Medical Oncology (ESMO) Congress

October 10, 2016
·
6 min read
Drug Development

Ipsen And Its Partner Exelixis Announce Positive Results From Phase 2 CABOSUN Trial Of Cabozantinib Versus Sunitinib In Previously Untreated Advanced Renal Cell Carcinoma Presented At The European Society For Medical Oncology (ESMO) 2016 Congress

October 10, 2016
·
17 min read
NOXXON Pharma AG Demonstrates Synergies Between NOX-A12 And Therapies Working Through T Cells Or NK Cells

October 10, 2016
·
2 min read